Search Result "Hematologic tox"
Exploring Old Drugs for the Treatment of Hematological Malignancies
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 1509-1514
Author(s): F. Gan, B. Cao, D. Wu, Z. Chen, T. Hou, X. Mao
Targeting the RAS Signaling Pathway in Malignant Hematologic Diseases
Journal: Current Drug Targets
Volume: 8 Issue: 2 Year: 2007 Page: 217-235
Author(s): M. A. Morgan, A. Ganser, C. W. M. Reuter
Immunotoxins in the Treatment of Hematologic Malignancies
Journal: Current Drug Targets
Volume: 7 Issue: 1 Year: 2006 Page: 1301-1311
Author(s): Robert J. Kreitman, Ira Pastan
Clinical Studies with Bismuth-213 and Actinium-225 for Hematologic Malignancies
Journal: Current Radiopharmaceuticals
Volume: 11 Issue: 3 Year: 2018 Page: 192-199
Author(s): Joseph G. Jurcic
Molecular Modeling of Peptide Derivatives NS3 Protease Inhibitors of the Type 2 Dengue Virus
Journal: Current Physical Chemistry
Volume: 6 Issue: 1 Year: 2016 Page: 28-39
Author(s):
Chemical and Clinical Development of Darinaparsin, a Novel Organic Arsenic Derivative
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 8 Issue: 8 Year: 2008 Page: 904-909
Author(s): Alfonso Quintas-Cardama, Srdan Verstovsek, Emil Freireich, Hagop Kantarjian, Yi Wen Chen, Ralph Zingaro
Immunotherapy of Human Cancers Using Gene Modified T Lymphocytes
Journal: Current Gene Therapy
Volume: 9 Issue: 5 Year: 2009 Page: 396-408
Author(s): Juan F. Vera, Malcolm K. Brenner, Gianpietro Dotti
Biodistribution, Safety and Organ Toxicity of Docetaxel-Loaded in HER-2 Aptamer Conjugated Ecoflex® Nanoparticles in a Mouse Xenograft Model of Ovarian Cancer
Journal: Recent Patents on Nanotechnology
Volume: 13 Issue: 1 Year: 2019 Page: 49-58
Author(s): Erfaneh Ghassami,Jaleh Varshosaz,Mohsen Minaiyan,Mehrab Nasirikenari,Seyed Mohammad Hoseini
Advances in Anticancer Antibody-Drug Conjugates and Immunotoxins
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 9 Issue: 1 Year: 2014 Page: 35-65
Author(s): Franco Dosio,Barbara Stella,Sofia Cerioni,Daniela Gastaldi,Silvia Arpicco
Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 3 Year: 2011 Page: 254-284
Author(s): B. C. Potts, M. X. Albitar, K. C. Anderson, S. Baritaki, C. Berkers, B. Bonavida, J. Chandra, D. Chauhan, J. C. Cusack, W. Fenical, I. M. Ghobrial, M. Groll, P. R. Jensen, K. S. Lam, G. K. Lloyd, W. McBride, D. J. McConkey, C. P. Miller, S. T.C. Neuteboom, Y. Oki, H. Ovaa, F. Pajonk, P. G. Richardson, A. M. Roccaro, C. M. Sloss, M. A. Spear, E. Valashi, A. Younes, M. A. Palladino